The largest database of trusted experimental protocols

6 protocols using pe conjugated anti human cd31

1

Isolation and Expansion of Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iECs were isolated and expanded as described previously.[66, 67] In brief, CD31‐expressing cells were isolated via magnetic‐activated cell sorting (MACS; Miltenyi Biotec Bergisch Gladbach), following the manufacturer's protocol, on day 8 of differentiation. After rinsing the cells with 1x phosphate‐buffered saline (PBS; Thermo Fisher Scientific), cells were trypsinized with TrypLE Express and resuspended in MACS buffer (0.5 Ethylenediaminetetraacetic acid [MilliporeSigma] and 0.5% Bovine Serum Albumin (BSA; [MilliporeSigma] in PBS). After resuspension, cells were incubated with 10 µL of PE‐conjugated anti‐human CD31 (BD Biosciences) for 10 min at 4 °C. To remove the unbound primary antibody, cells were washed twice with MACS buffer. After washing, cells were resuspended in 80 µL MACS buffer, and 20 µL of anti‐PE microbeads (Miltenyi Biotec Bergisch Gladbach) were added to the cell suspension. Cells were incubated for an additional 15 min at 4 °C, followed by a washing step with MACS buffer before separation using the MS MACS separation column (Miltenyi Biotec Bergisch Gladbach). Finally, CD31+ cells were seeded on collagen type I‐coated plates and maintained in ECGM supplemented with 50 ng mL−1 VEGF and 10 × 10−6 m SB‐431542.
+ Open protocol
+ Expand
2

Isolation of Epithelial Cells from Normal Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assess epithelial cell marker expression on normal tissue, single cells were blocked in phosphate‐buffered saline (PBS) containing 2% FCS, 10% DNase, rat immunoglobulin (Jackson Immunolabs), and antibodies to CD16 and CD32 Fcγ II and III receptors (WEHI Monoclonal Antibody Facility) for 10 min at 4°C. Cells were then incubated with the following antibodies for 25 min at 4°C: PE‐conjugated anti‐human CD31 (BD Pharmingen; clone WM59; 1/40), PE‐conjugated anti‐human CD45 (BD Pharmingen; clone H130; 1/120), PE‐conjugated anti‐human CD235a (BD Pharmingen; clone GA‐R2; 1/120), FITC‐conjugated anti‐human CD236 (EpCAM; Stem Cell Technologies; clone VU‐1D9; 1/40), and APC‐Cy7‐conjugated anti‐human CD49f (integrin a6; clone GoH3; 1/120). Cells were then washed with PBS/2% FCS and resuspended in 7‐AAD (0.2 mg/ml) for live‐cell discrimination. Cells were sorted on a FACSAria flow cytometer (Becton Dickinson). For normal tissue, lineage‐negative (depleted for CD45, CD31, CD235a lineage‐positive cells), epithelial cells (EpCAM+CD49f + EpCAM+CD49f+ + EpCAMCD49f+) were sorted.
+ Open protocol
+ Expand
3

Immunophenotyping of Adipose-Derived MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunophenotype analysis was performed on the AD-MSC samples after 4 passages labeled with the following monoclonal antibodies: FITC-conjugated anti-human HLA-DR (BD), PE-conjugated anti-human CD31 (BD), CD105 (ebioscience, Waltham, MA, USA), CD73 (BD), PerCP-conjugated anti-human CD45 (BD), APC-conjugated anti-human CD90 (ebioscience), CD14 (BD), CD146 (BD), and unconjugated anti-human GD2 (BD) with an APC-conjugated secondary antibody (BD), in addition to the appropriate isotype controls (BD Pharmigen and BD). The AD-MSCs were analyzed with a FACSARIA III equipped with BD CellQuest ProTM software (BD, Franklin Lake, NJ, USA), and 10,000 events were acquired.
+ Open protocol
+ Expand
4

Quantifying Endothelial and Platelet Microparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify the levels of EMPs and PMPs within samples, PPP samples were mixed with 10 μm flow counting beads (Beckman Coulter, UK) in the presence of calcium-rich buffer (eBioscience, UK). Analysis of the MP populations was carried out using a cocktail of phycoerythrin (PE) -conjugated anti-human CD31 (BD Bioscience, UK), allophycocyanin (APC) -conjugated anti-human CD42b (BD Bioscience, UK) and efluor450 annexin-V marker (eBioscience, UK) as previously described34 (link). MPs were analysed using a Cyan flow cytometer (BD Biosciences) according to their size and fluorescence using a logFS-logSS plot. EMPs were characterised and enumerated as Annexin V+/CD31+/CD42b- events, and PMPs as Annexin V+/CD31+/CD42b+ events (Supplementary Fig. S1).
+ Open protocol
+ Expand
5

Isolation and Culture of CD31+ Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD31 expressing cells were isolated on day 8 of differentiation via magnetically activated cell sorting (MACS; Miltenyi Biotec Bergisch Gladbach, Germany) following the manufacturer’s protocol. After washing with 1× phosphate-buffered saline (PBS, ThermoFisher Scientific), cells were harvested with TrypLE Express and resuspended in MACS buffer (0.5 EDTA and 0.5% BSA in PBS). Cells were then incubated with 10 μl of PE-conjugated anti-human CD31 (BD Biosciences, San Jose, CA) for 10 min at 4 °C. After incubation, the unbound primary antibody was removed by washing with MACS buffer twice. Next, 20 μl of anti-PE microbeads (Miltenyi Biotec Bergisch Gladbach, Germany) were added to 80 μl of cells suspended in MACS buffer and incubated for an additional 15 min at 4 °C. Cells were washed with MACS buffer and separated using the MS MACS separation column (Miltenyi Biotec). Following separation, CD31 and VECAD enrichment were confirmed using flow cytometry as previously71 (link) and detailed below in a separate section. Finally, CD31+ cells were seeded on type I collagen-coated plates and maintained in EC differentiation media. For all experiments, media was switched to ECGM without growth factor supplementation for 24 h unless otherwise noted. All experiments used iECs between passages 1 and 3.
+ Open protocol
+ Expand
6

Multicolor Flow Cytometry of Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were blocked with rat immunoglobulin (Jackson ImmunoLabs) and antibody to Fc receptor–binding inhibitor (eBioscience) before incubation with the following primary antibodies: phycoerythrin (PE)–conjugated anti-human CD31 (BD Pharmingen), PE-conjugated anti-human CD45 (BD Pharmingen), PE-conjugated anti-human CD235a (BD Pharmingen), BV650-conjugated anti-human epithelial cell adhesion molecule (EpCAM) CD326 (BioLegend), and biotin-conjugated anti-human ITGA6 (eBioscience). Where required, cells were incubated with allophycocyanin-Cy7–conjugated streptavidin (BD Pharmingen). Cells were either stained with 4′,6-diamidino-2-phenylindole (DAPI) for viability or fixed with 1% paraformaldehyde and stained with the Zombie Aqua Fixable Viability Kit (BioLegend). Viable cells were sorted on a FACSAria flow cytometer (Becton Dickinson). Data were analyzed using FlowJo software (Tree Star).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!